Canopy Growth (CGC) Other Non Operating Income (2019 - 2025)

Canopy Growth (CGC) reported Other Non Operating Income of -$29.7 million for Q4 2025, up 43.86% on a YoY basis from -$20.7 million in Q4 2024, and down 437.17% sequentially from $8.8 million in Q3 2025.

Canopy Growth (CGC) Other Non Operating Income (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Other Non Operating Income data on file, last reported at -$29.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 43.86% year-over-year to -$29.7 million; the trailing twelve-month figure through Dec 2025 stood at -$89.7 million (down 598.01% YoY), and the FY2026 full-year result was -$1.1 million, up 99.59% from the prior year.
  • Other Non Operating Income slipped to -$29.7 million in Q4 2025, from $8.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $172.4 million in Q1 2024 to a low of -$646.8 million in Q1 2022.
  • A 5-year average of -$52.0 million and a median of -$15.8 million in 2025 frame the typical range for Other Non Operating Income.
  • Across the five-year window, Other Non Operating Income slumped 141034.7% in 2022 and soared 8409.42% in 2024, its largest moves.
  • Tracing CGC's Other Non Operating Income over 5 years: stood at $785402.7 in 2021, then sank by 10932.89% to -$85.1 million in 2022, then plunged by 38.05% to -$117.5 million in 2023, then jumped by 54.93% to -$52.9 million in 2024, then soared by 43.86% to -$29.7 million in 2025.
  • Business Quant data shows CGC's Other Non Operating Income at -$29.7 million in Q4 2025, $8.8 million in Q3 2025, and -$15.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -29.72 Mn
Sep 30, 2025 8.81 Mn
Jun 30, 2025 -15.84 Mn
Dec 31, 2024 -52.93 Mn
Sep 30, 2024 -48.36 Mn
Jun 30, 2024 -53.10 Mn
Mar 31, 2024 172.40 Mn
Dec 31, 2023 -117.46 Mn
Sep 30, 2023 -89.30 Mn
Jun 30, 2023 -103,478.89
Mar 31, 2023 2.03 Mn
Dec 31, 2022 -85.08 Mn
Sep 30, 2022 -29.96 Mn
Jun 30, 2022 -3.87 Mn
Mar 31, 2022 -646.76 Mn
Dec 31, 2021 785,402.72
Sep 30, 2021 700,669.01
Jun 30, 2021 837,932.97
Mar 31, 2021 -458,257.49
Dec 31, 2020 544,608.81